Poloxamer 407 is an investigational drug.
There have been 4 clinical trials for Poloxamer 407.
The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2011.
The most common disease conditions in clinical trials are Mucositis, Stomatitis, and Periodontitis. The leading clinical trial sponsors are University of Iowa, Ahmed Mohamed Mahrous, and Maha Talaab.